These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18224541)

  • 1. Hormone catalysis: role of protecting and modifying reagents of sulfhydryl groups on estrogen receptor in breast cancer.
    Salazar EL; Calzada L
    Gynecol Endocrinol; 2008 Jan; 24(1):30-2. PubMed ID: 18224541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
    Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
    Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
    Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
    Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
    Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates.
    Ahmed N; Dubuc C; Rousseau J; Bénard F; van Lier JE
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3212-6. PubMed ID: 17379515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Barnett DH; Sheng S; Charn TH; Waheed A; Sly WS; Lin CY; Liu ET; Katzenellenbogen BS
    Cancer Res; 2008 May; 68(9):3505-15. PubMed ID: 18451179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
    Rachner TD; Schoppet M; Niebergall U; Hofbauer LC
    Biochem Biophys Res Commun; 2008 Apr; 368(3):736-41. PubMed ID: 18252198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.
    Stute P; Szuwart T; Schlueter M; Götte M; Packeisen J; Kiesel L
    Maturitas; 2008 Feb; 59(2):163-73. PubMed ID: 18261865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
    Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
    Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells.
    Hu DG; Mackenzie PI
    Mol Pharmacol; 2009 Aug; 76(2):425-39. PubMed ID: 19487245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.
    Spears M; Bartlett J
    Expert Opin Ther Targets; 2009 Jun; 13(6):665-74. PubMed ID: 19456271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
    Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on a possible simultaneous differential demonstration of SH groups and S-S bonds.
    Szydlowska H; Junikiewicz E
    Folia Histochem Cytochem (Krakow); 1973 Apr; 11(2):105-10. PubMed ID: 4131770
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
    Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
    Chen XN; Zhu H; Meng QY; Zhou JN
    Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
    Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
    Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodinated ligands for the estrogen receptor: effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6-dehydroestradiols.
    Neto C; Oliveira MC; Gano L; Marques F; Santos I; Morais GR; Yasuda T; Thiemann T; Botelho F; Oliveira CF
    Appl Radiat Isot; 2009 Feb; 67(2):301-7. PubMed ID: 19049850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
    Rokavec M; Schroth W; Amaral SM; Fritz P; Antoniadou L; Glavac D; Simon W; Schwab M; Eichelbaum M; Brauch H
    Cancer Res; 2008 Dec; 68(23):9799-808. PubMed ID: 19047159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.